Business / Finance

RSS

Oncothyreon 2010 net loss decreases to 15.6 million

Oncothyreon Inc. today reported financial results for the year and quarter ending December 31, 2010.

10 Mar 2011

Columbia fourth quarter total net revenues increase 74% to $14.9 million

Columbia Laboratories, Inc. today reported financial results for the three- and twelve-month periods ended December 31, 2010.

10 Mar 2011

China Health Labs & Diagnostics begins trading on OTCQX International

China Health Labs & Diagnostics Ltd., is pleased to announce that effective March 10, 2011 its shares began trading on the OTC Market's premier tier, OTCQX International, under the symbol CHLBF.

10 Mar 2011

Northstar fourth quarter net patient service revenue decreases to $2.2 million

Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters -- one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico -- have been resolved.

10 Mar 2011

Medtronic opens new manufacturing facility in Singapore

Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore Operations. The facility will enhance the company's manufacturing capabilities to meet the future expected growth of cardiac devices in Asia.

10 Mar 2011

NextGen Group subsidiary completes commercial reorganization

NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.

10 Mar 2011

Alliance fourth quarter revenue decreases to $117.7 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the fourth quarter and year ended December 31, 2010.

9 Mar 2011

CHSI enters definitive agreement to acquire WHI for $525 million

Catalyst Health Solutions, Inc. announced that it has entered into a definitive agreement with Walgreen Co. to acquire Walgreens' pharmacy benefit management subsidiary, Walgreens Health Initiatives, Inc., for $525 million in cash.

9 Mar 2011

NovaShunt raises Series B financing for CHF 23.7 million

NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund.

9 Mar 2011

Fluidigm fourth quarter revenue increases to $10.4 million

Fluidigm Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2010.

9 Mar 2011

U.S. Bank introduces two enhanced offerings for healthcare providers

U.S. Bank's healthcare payments division today introduced two enhanced offerings—Payment Navigator and Payment Consolidator—that help healthcare providers improve revenue cycles and streamline complex payment processes, at a time when providers face unprecedented challenges getting paid for their services.

9 Mar 2011

Trade name ‘The Stem Cell Group’ registered for Celulas Genetica

Emerging Healthcare Solutions, Inc. announced today that it registered a trade name, "The Stem Cell Group," for use in marketing and branding its subsidiary company, Celulas Genetica.

9 Mar 2011

Allergy Asthma Research Institute, Forest Labs join SAFE-BioPharma

In a move to improve efficiency by reducing paper in their respective operations, Forest Laboratories and the Allergy Asthma Research Institute have joined SAFE-BioPharma Association. They now have access to the SAFE-BioPharma® digital identity and signature standard, used throughout the biopharmaceutical industry to verify and manage digital identities involved in electronic transactions and to apply digital signatures to electronic documents.

9 Mar 2011

Swisher Hygiene announces acquisition of healthcare and hospitality division of SPS, ADCO

Swisher Hygiene Inc., a leading provider of essential hygiene and sanitation products and services, today announced that it has acquired the healthcare and hospitality division of Solvents and Petroleum Service, Inc., a New York-based hygiene and chemicals company, and ADCO Services, Inc., an Atlanta-based hygiene and chemicals company.

8 Mar 2011

CNIT fourth quarter revenues increase 94.1% to US$61.22 million

Information Technology, Inc., a leading total solutions provider of geographic information systems, digital public security technology and digital hospital information systems in China, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2010.

8 Mar 2011

Bristol-Myers Squibb enters strategic partnership with WuXi Pharmatech

Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

RadNet fourth quarter revenues increase 10.2% to $13.5 million

RadNet, a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 201 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full year ended December 31, 2010.

8 Mar 2011